Table: Daito -2016/17 group results

Daito Pharmaceutical

11/07/2017 07:00

Jul 11 (Reuters)-  
          Daito Pharamaceutical Co Ltd  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to       NEXT    
              May 31, 2017    May 31, 2016   May 31, 2018     YEAR      
                 LATEST         YEAR-AGO        COMPANY      COMPANY    
                 RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales           37.98           36.37          40.50        19.90     
               (+4.4 pct)      (+6.8 pct)     (+6.6 pct)    (+3.5 pct)  
  Operating        3.83            3.56           4.10         2.00     
               (+7.8 pct)      (+1.0 pct)     (+7.0 pct)    (-5.9 pct)  
  Recurring        3.88            3.71           4.15         2.04     
               (+4.4 pct)      (+7.6 pct)     (+7.0 pct)    (-2.1 pct)  
  Net 
  Net              2.66            2.57           2.85         1.40     
               (+3.5 pct)      (+14.3 pct)    (+7.3 pct)    (-1.7 pct)  
  EPS          212.26 yen      205.07 yen     227.74 yen    111.87 yen  
  Ann Div       33.00 yen       30.00 yen      30.00 yen                
  -Q2 Div       15.00 yen       15.00 yen      15.00 yen                
  -Q4 Div       18.00 yen       15.00 yen      15.00 yen                
   
  NOTE - Daito Pharamaceutical Co Ltd. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T 
  ((Tokyo Headline News Desk +813 6441 1812))